Elix, the patient centric platform for clinical trials, promotes continuous patient engagement increasing retention & stickiness supported by ai agent, integrates with most of the major EHR systems.
Monitored by proprietary agent, elix will make it easy for patients to comply with clinical trial protocol specification.
make it easy for patients and subjects to freely share/express information about the treatment or symptoms from their own comfortable zone, in a secured community setting under elix vigilance.
let elix use the patent pending signal detection and pass through to incumbent pharmacovigilance systems with seamless integrations.
go from requirements to operationalizing in phase III & phase IV clinical trials to post product launch with elix in no time.
patient demographics, target audience, regional site associated inclusion and exclusion criteria screening and recruiting
e-consent, personalized site specific protocol info, continuous patient engagement, keeping patient upto date with their treatment progress with integration to EHR systems hub.
with native NLP support, elix can be configured to leverage deep learning and ai based dynamic workflows
with extensible elix bot rendering framework and api, customizing integrations with your existing pharmacovigilance systems is a breeze.
as consumers are embracing the pace of innovation, companies want to better position themselves to provide the best customer experience. with the help of elix, reach your patients & subjects in their own comfort zone.
reduced manual intervention to review ICSRs by customizing elix confidence levels. with patent pending signal monitoring, early signal detection and signal evaluation, the pharma companies will have an ability to proactively take measures to avoid potential drug recalls.